Triple
T5457164
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | MacAndrews & Forbes |
E122506
|
entity |
| Predicate | hasInvestmentIn |
P17330
|
FINISHED |
| Object |
SIGA Technologies
SIGA Technologies is a pharmaceutical company specializing in the development of antiviral treatments, particularly for smallpox and other orthopoxvirus infections.
|
E521269
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69bd46424248819085282ddf50a565f3 |
elicitation | completed |
| NER | batch_69bd964583008190bf7b94f656e4ecf2 |
ner | completed |
| NED1 | batch_69bf41465c3c8190a58350f39d626e54 |
ned_source_triple | completed |
| NED2 | batch_69bf42654a108190b271f78616eea25a |
ned_description | completed |
| NEDg | batch_69bf41efb7748190acefa796eb4e4bed |
nedg | completed |
Created at: March 20, 2026, 2:08 p.m.